4.7 Article

Presynaptic Type III Neuregulin1-ErbB signaling targets α7 nicotinic acetylcholine receptors to axons

Journal

JOURNAL OF CELL BIOLOGY
Volume 181, Issue 3, Pages 511-521

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.200710037

Keywords

-

Categories

Funding

  1. NIDA NIH HHS [DA019941, R21 DA019941] Funding Source: Medline
  2. NIDDK NIH HHS [DK07328, T32 DK007328] Funding Source: Medline
  3. NINDS NIH HHS [NS29071, R01 NS029071, R01 NS029071-17] Funding Source: Medline

Ask authors/readers for more resources

Type III Neuregulin1 (Nrg1) isoforms are membrane-tethered proteins capable of participating in bidirectional juxtacrine signaling. Neuronal nicotinic acetylcholine receptors (nAChRs), which can modulate the release of a rich array of neurotransmitters, are differentially targeted to presynaptic sites. We demonstrate that Type III Nrg1 back signaling regulates the surface expression of alpha 7 nAChRs along axons of sensory neurons. Stimulation of Type III Nrg1 back signaling induces an increase in axonal surface alpha 7 nAChRs, which results from a re-distribution of preexisting intracellular pools of alpha 7 rather than from increased protein synthesis. We also demonstrate that Type III Nrg1 back signaling activates a phosphatidylinositol 3-kinase signaling pathway and that activation of this pathway is required for the insertion of preexisting alpha 7 nAChRs into the axonal plasma membrane. These findings, in conjunction with prior results establishing that Type III Nrg1 back signaling controls gene transcription, demonstrate that Type III Nrg1 back signaling can regulate both short-and long-term changes in neuronal function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available